Lombertie E R, Durelle G, Fuseau A
Unité de traitement des Psychoses, S.H.U. de Psychiatrie Secteur IV, Limoges.
Ann Med Psychol (Paris). 1995 Oct;153(8):531-4.
Use and interest of therapeutic association bromocriptine-neuroleptic in schizophrenia. Twelve schizophrenic patients were treated by bromocriptine (7.5 mg.day) and neuroleptic. After one month, patients on this treatment showed a mean improvement of 29% on the total score of the positive and negative symptom scale. This results suggest that therapeutic association bromocriptine-neuroleptic may be used for schizophrenic patients.
